Community Home

A Message from the President Immunotherapies have clearly transformed cancer treatments in recent years. However, the increased focus on developing more effective cancer immunotherapies has highlighted some of the biological, clinical, and regulatory ...

In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists and professionals in oncology-related ...

The Global Access and Impact Committee, in collaboration with the Diversity, Equity, and Inclusion Committee, is pleased to launch SITC's first educational program crafted specifically for international audiences, titled " Increasing Access to IO: A Global ...

MILWAUKEE – The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a new manuscript “ Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from pre-malignant ...

On behalf of the society and the SITC Intratumoral Immunotherapy Clinical Trials Manuscript Development Group, we are pleased to announce the publication of a new manuscript “ Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral ...